The surgery comes at a turning point in the quest to tell if animal-to-human transplants could help ease the shortage of ...

The second person ever has received a transplant with a genetically modified pig kidney.

The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

Doctors at Massachusetts General Hospital transplanted a pig kidney into a 66-year-old patient with end-stage kidney disease.

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Tim Andrews, 66, was diagnosed with end-stage kidney disease more than two years ago. Since then, he's treated his condition ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

Mass General Brigham has announced the successful completion of another gene-edited pig kidney transplant, the first of a ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...